查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886579

透明質酸酶市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、地區和競爭格局分類，2020-2030年預測

Hyaluronidase Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球透明質酸酶市場規模為11.1億美元，預計2030年將以8.91%的複合年成長率成長至18.5億美元。透明質酸酶是一種能夠分解透明質酸（一種糖胺聚醣）的酶，從而降低組織黏度並促進物質在組織中的擴散。全球透明質酸酶市場的主要驅動力是微創美容手術需求的不斷成長，以及需要改進藥物輸送方式的疾病（尤其是在腫瘤學和眼科學領域）的日益增加。

市場概覽
預測期 2026-2030
市場規模：2024年 11.1億美元
市場規模：2030年 18.5億美元
複合年成長率：2025-2030年 8.91%
成長最快的細分市場 動物源性透明質酸酶
最大的市場 北美洲

主要市場促進因素

全球透明質酸酶市場受到美容和皮膚科手術需求激增的顯著影響。這種酵素對於糾正透明質酸填充劑併發症、確保患者安全以及在快速發展的美容領域提升治療效果至關重要。

主要市場挑戰

全球透明質酸酶市場面臨的一大挑戰是合成透明質酸酶變體的高生產成本。開發新型生物實體並將其推向市場需要大量的資金投入。

主要市場趨勢

全球市場正經歷著向重組和合成透明質酸酶製劑的顯著轉變，這主要得益於其純度更高、穩定性更強、免疫原性更低，優於動物源性製劑。這些先進的製劑能夠帶來更可預測的療效，並具有更廣泛的臨床應用價值。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球透明質酸酶市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（動物源性透明質酸酶、合成透明質酸酶）
    • 依應用領域（皮膚科、化療科、眼科、整形外科、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美玻尿酸酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲透明質酸酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區透明質酸酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲透明質酸酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲透明質酸酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球透明質酸酶市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Amphastar Pharmaceuticals, Inc.
  • PrimaPharma, Inc.,
  • Halozyme, Inc.
  • Bausch & Lomb Incorporated
  • The Cooper Companies Inc.,
  • Sun Pharmaceutical Industries Ltd.
  • STEMCELL Technologies Inc.
  • Shreya Life Sciences Pvt. Ltd.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22454

The Global Hyaluronidase Market, valued at USD 1.11 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 1.85 Billion by 2030. Hyaluronidase is an enzyme that degrades hyaluronic acid, a glycosaminoglycan, thereby reducing tissue viscosity and enhancing the diffusion of substances through tissues. The global hyaluronidase market is primarily driven by the increasing demand for minimally invasive cosmetic procedures and a rising prevalence of conditions necessitating improved drug delivery, particularly in oncology and ophthalmology.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.11 Billion
Market Size 2030USD 1.85 Billion
CAGR 2025-20308.91%
Fastest Growing SegmentAnimal Derived Hyaluronidase
Largest MarketNorth America

Key Market Drivers

The global hyaluronidase market is significantly influenced by the surging demand for aesthetic and dermatological procedures. This enzyme is crucial for correcting hyaluronic acid filler complications, ensuring patient safety and enhancing treatment outcomes in a rapidly expanding cosmetic landscape. For instance, according to the International Society of Aesthetic Plastic Surgery, in July 2025, their 2024 Global Survey on Aesthetic/Cosmetic Procedures reported that hyaluronic acid procedures grew by 5.2% to 6.3 million procedures worldwide in 2024, highlighting the increasing need for hyaluronidase for both primary procedures and complication management.

Key Market Challenges

The global hyaluronidase market encounters a significant challenging factor in the high production costs associated with synthetic hyaluronidase variants. Developing and bringing novel biological entities to market involves substantial financial investment. According to the European Federation of Pharmaceutical Industries and Associations, the cost of researching and developing a new chemical or biological entity was estimated at €3,130 million in 2022. This considerable outlay for research and development directly influences the final market price of synthetic hyaluronidase products, making them less accessible in various healthcare settings.

Key Market Trends

The shift towards recombinant and synthetic hyaluronidase formulations represents a significant trend in the global market, driven by enhanced purity, consistency, and reduced immunogenicity compared to animal-derived counterparts. These advanced formulations allow for more predictable outcomes and broader clinical utility. According to the FDA, in 2024, biologics accounted for 32% of all new drug approvals, marking a notable increase from the 28% average over the prior six years, underscoring the growing importance of such products in the pharmaceutical landscape.

Key Market Players

  • Amphastar Pharmaceuticals, Inc.
  • PrimaPharma, Inc.,
  • Halozyme, Inc.
  • Bausch & Lomb Incorporated
  • The Cooper Companies Inc.,
  • Sun Pharmaceutical Industries Ltd.
  • STEMCELL Technologies Inc.
  • Shreya Life Sciences Pvt. Ltd.

Report Scope:

In this report, the Global Hyaluronidase Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hyaluronidase Market, By Type:

  • Animal Derived Hyaluronidase
  • Synthetic Hyaluronidase

Hyaluronidase Market, By Application:

  • Dermatology
  • Chemotherapy
  • Ophthalmology
  • Plastic Surgery
  • Others

Hyaluronidase Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hyaluronidase Market.

Available Customizations:

Global Hyaluronidase Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hyaluronidase Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Animal Derived Hyaluronidase, Synthetic Hyaluronidase)
    • 5.2.2. By Application (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Hyaluronidase Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hyaluronidase Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Hyaluronidase Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Hyaluronidase Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Hyaluronidase Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hyaluronidase Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Hyaluronidase Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Hyaluronidase Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Hyaluronidase Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Hyaluronidase Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Hyaluronidase Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hyaluronidase Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Hyaluronidase Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Hyaluronidase Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Hyaluronidase Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Hyaluronidase Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Hyaluronidase Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hyaluronidase Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Hyaluronidase Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Hyaluronidase Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Hyaluronidase Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hyaluronidase Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Hyaluronidase Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Hyaluronidase Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hyaluronidase Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Amphastar Pharmaceuticals, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. PrimaPharma, Inc.,
  • 15.3. Halozyme, Inc.
  • 15.4. Bausch & Lomb Incorporated
  • 15.5. The Cooper Companies Inc.,
  • 15.6. Sun Pharmaceutical Industries Ltd.
  • 15.7. STEMCELL Technologies Inc.
  • 15.8. Shreya Life Sciences Pvt. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer